epidermal-growth-factor and Eye-Injuries--Penetrating

Previous reports indicated that pregnancy and corneal injury (CI) trigger alterations of lacrimal gland (LG) growth factor expression and redistributions of lymphocytes from periductal foci to acini. The purpose of this study was to test our hypothesis that pregnancy would exacerbate the changes induced by CI.. Corneas were injured with scalpel blades, and, 2 weeks later, LGs were collected for immunocytochemistry and Western blot analysis. Lacrimal fluid was collected under basal- and pilocarpine-stimulated conditions for protein determination and Western blot analyses.. There were significant increases of immunoreactivity for prolactin, TGF-beta1, and EGF in duct cells during pregnancy and after CI, most prominent in pregnant animals with CI. Pregnancy decreased baseline lacrimal fluid secretion, whereas CI did not have a noticeable effect; pregnancy and CI combined resulted in increased fluid production. Pregnancy and CI each increased pilocarpine-induced lacrimal fluid production, whereas protein concentrations were decreased. Prolactin, TGF-beta1, and EGF were detected in LG by Western blot analysis but were minimally detectable in lacrimal fluid. RTLA+ and CD18+ cells were redistributed from periductal to interacinar sites during pregnancy and after CI, most prominent in pregnant animals with CI.. Like pregnancy, CI is associated with redistribution of immune cells from periductal to interacinar sites and enhanced immunoreactivity of prolactin, TGF-beta1, and EGF in ductal cells. Although baseline lacrimal fluid secretion varied, the glands of all three experimental groups produced significant amounts of fluid in response to pilocarpine, but protein concentrations were decreased.

Topics: Animals; Blotting, Western; Cornea; Corneal Injuries; Electrophoresis, Polyacrylamide Gel; Epidermal Growth Factor; Eye Injuries, Penetrating; Female; Immunohistochemistry; Lacrimal Apparatus; Muscarinic Agonists; Pilocarpine; Pregnancy; Pregnancy, Animal; Prolactin; Rabbits; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1

To determine whether epidermal growth factor (EGF) accelerates the healing of corneal tissue, we measured the tensile strength, ductility (total deformation at rupture) and toughness of 60 rabbit corneas with 7-mm perforating wounds after topical treatment with EGF or saline for 8, 13 or 23 days. The three mechanical properties were measured using corneal strips mounted on an Instron tensometer. A traction speed of 5 cm/min was chosen from speed-response curves for the three measures of interest. Since the values for eyes of a single rabbit were correlated, we used the data for one eye, selected at random, from each animal in the data analysis. EGF enhanced tensile strength (p = 0.003) and toughness (p = 0.03) of corneas without reducing ductility. The difference in tensile strength and toughness between EGF- and saline-treated corneas was more striking at 8 and 13 days than at 23 days. Histologic studies at 13 and 23 days supported these observations: at 13 days the healing process was more advanced in EGF-treated corneas, whereas at 23 days no histologic differences were noted. We conclude that EGF accelerates wound healing in rabbit corneas with perforating wounds without reducing ductility of the corneal tissue.

Topics: Administration, Topical; Animals; Cornea; Corneal Injuries; Elasticity; Epidermal Growth Factor; Eye Injuries, Penetrating; Female; Ophthalmic Solutions; Rabbits; Tensile Strength; Wound Healing